358 related articles for article (PubMed ID: 28597609)
1. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Dimonaco S; Brockwell L
Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
[TBL] [Abstract][Full Text] [Related]
2. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
[TBL] [Abstract][Full Text] [Related]
3. Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
Drug Saf; 2018 Jun; 41(6):625-640. PubMed ID: 29492878
[TBL] [Abstract][Full Text] [Related]
4. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
Gupta R; Bhatia J; Gupta SK
Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
[TBL] [Abstract][Full Text] [Related]
5. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.
Watkins PB; Dube LM; Walton-Bowen K; Cameron CM; Kasten LE
Drug Saf; 2007; 30(9):805-15. PubMed ID: 17722971
[TBL] [Abstract][Full Text] [Related]
6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Shi Q; Zhao Y; Bao CD; Li XF; Huang F; Zhu P; Li ZG; Gu JR; Zhang ZY; Zhao DB; Zhao SL; Jiang QD; Tian J; Zhang FC
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):323-9. PubMed ID: 23925361
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.
Shamseddeen H; Vilar-Gomez E; Chalasani N; Myers RP; Subramanian GM; Shlevin HH; Allgood AE; Orman ES
Drug Saf; 2020 Mar; 43(3):281-290. PubMed ID: 31907854
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials.
Kuffner EK; Temple AR; Cooper KM; Baggish JS; Parenti DL
Curr Med Res Opin; 2006 Nov; 22(11):2137-48. PubMed ID: 17076974
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources.
Curtis JR; Perez-Gutthann S; Suissa S; Napalkov P; Singh N; Thompson L; Porter-Brown B;
Semin Arthritis Rheum; 2015 Feb; 44(4):381-8. PubMed ID: 25300699
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of atorvastatin in a population aged > or =65 years: a retrospective pooled analysis of results from fifty randomized clinical trials.
Hey-Hadavi JH; Kuntze E; Luo D; Silverman P; Pittman D; Lepetri B
Am J Geriatr Pharmacother; 2006 Jun; 4(2):112-22. PubMed ID: 16860258
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients.
Stern JO; Robinson PA; Love J; Lanes S; Imperiale MS; Mayers DL
J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S21-33. PubMed ID: 14562855
[TBL] [Abstract][Full Text] [Related]
15. Results from a 2-year centralized tolcapone liver enzyme monitoring program.
Lew MF; Kricorian G
Clin Neuropharmacol; 2007; 30(5):281-6. PubMed ID: 17909306
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.
Watkins PB; Zimmerman HJ; Knapp MJ; Gracon SI; Lewis KW
JAMA; 1994 Apr; 271(13):992-8. PubMed ID: 8139084
[TBL] [Abstract][Full Text] [Related]
17. Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.
Dirven L; Klarenbeek NB; van den Broek M; van Groenendael JH; de Sonnaville PB; Kerstens PJ; Huizinga TW; Dijkmans BA; Lems WF; Allaart CF
Clin Rheumatol; 2013 May; 32(5):585-90. PubMed ID: 23224330
[TBL] [Abstract][Full Text] [Related]
18. Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.
Moots RJ; Sebba A; Rigby W; Ostor A; Porter-Brown B; Donaldson F; Dimonaco S; Rubbert-Roth A; van Vollenhoven R; Genovese MC
Rheumatology (Oxford); 2017 Apr; 56(4):541-549. PubMed ID: 28013198
[TBL] [Abstract][Full Text] [Related]
19. Clinical safety of tocilizumab in rheumatoid arthritis.
Bannwarth B; Richez C
Expert Opin Drug Saf; 2011 Jan; 10(1):123-31. PubMed ID: 21121872
[TBL] [Abstract][Full Text] [Related]
20. Hepatic findings in long-term clinical trials of ximelagatran.
Lee WM; Larrey D; Olsson R; Lewis JH; Keisu M; Auclert L; Sheth S
Drug Saf; 2005; 28(4):351-70. PubMed ID: 15783243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
